This article explores those differences in depth—covering origin, chemistry, pharmacology, effects, and legal status—while ...

The report provides a detailed analysis of the current acute pain marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- The acute pain market ...

Between September 2023 and September 2024, the CDC reported a staggering 24% decrease in opioid overdose deaths—the largest ...

CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

Both nicotine cravings and levels of cotinine significantly fell in adults treated with cytisinicline vs. placebo who failed ...

Furthermore, glycine ameliorates hepatic inflammation by inhibiting the nuclear factor-kappa B signalling pathway through glycine receptors. Combination therapy with IFN-α effectively suppressed HBV ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently diagnosed with Parkinson’s Disease ...

THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe form of liver disease. Learn more.

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D ...

GLP-1 receptor agonists also reduced the risk of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and all-cause mortality, with high-certainty evidence.